Alessia Santi

675 total citations
8 papers, 263 citations indexed

About

Alessia Santi is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Alessia Santi has authored 8 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Alessia Santi's work include Chronic Lymphocytic Leukemia Research (6 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Melanoma and MAPK Pathways (3 papers). Alessia Santi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Melanoma and MAPK Pathways (3 papers). Alessia Santi collaborates with scholars based in Italy, Germany and Slovakia. Alessia Santi's co-authors include Brunangelo Falini, Gianluca Schiavoni, Enrico Tiacci, Giorgio Inghirami, Valentina Pettirossi, Livio Trentin, Debora Cecchini, Paola Francia di Celle, Robin Foà and Maria Paola Martelli and has published in prestigious journals such as Blood, Cancer Research and Leukemia.

In The Last Decade

Alessia Santi

7 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessia Santi Italy 4 214 127 115 82 72 8 263
Elsa Maître France 10 199 0.9× 146 1.1× 80 0.7× 117 1.4× 64 0.9× 25 266
Nicole Weit Germany 6 110 0.5× 79 0.6× 72 0.6× 105 1.3× 62 0.9× 7 203
Václav Šeda Czechia 6 172 0.8× 118 0.9× 114 1.0× 142 1.7× 75 1.0× 6 333
Felicia Gomez United States 4 114 0.5× 200 1.6× 47 0.4× 52 0.6× 137 1.9× 8 250
Josef Karban Czechia 8 140 0.7× 102 0.8× 133 1.2× 113 1.4× 61 0.8× 31 300
Stefan Koehrer United States 9 110 0.5× 69 0.5× 125 1.1× 69 0.8× 83 1.2× 14 287
Jeffrey C. Xing United States 9 83 0.4× 102 0.8× 177 1.5× 75 0.9× 78 1.1× 14 350
Rose Mantel United States 8 254 1.2× 193 1.5× 112 1.0× 76 0.9× 59 0.8× 13 327
John Hanna United States 4 210 1.0× 139 1.1× 77 0.7× 98 1.2× 58 0.8× 6 262
Dejan Radeski Australia 9 34 0.2× 98 0.8× 164 1.4× 45 0.5× 140 1.9× 20 307

Countries citing papers authored by Alessia Santi

Since Specialization
Citations

This map shows the geographic impact of Alessia Santi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Santi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Santi more than expected).

Fields of papers citing papers by Alessia Santi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Santi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Santi. The network helps show where Alessia Santi may publish in the future.

Co-authorship network of co-authors of Alessia Santi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Santi. A scholar is included among the top collaborators of Alessia Santi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Santi. Alessia Santi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Duminuco, Andrea, et al.. (2025). Classic Hairy Cell Leukemia With MAP2K1 Mutation: Diagnosis and Targeted Therapy. American Journal of Hematology. 101(2). 339–340.
2.
Pettirossi, Valentina, Alessandra Venanzi, Ariele Spanhol-Rosseto, et al.. (2023). The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor. Leukemia. 37(2). 473–477. 3 indexed citations
3.
Tiacci, Enrico, Luca De Carolis, Edoardo Simonetti, et al.. (2021). Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial. Leukemia. 35(11). 3314–3318. 26 indexed citations
4.
Marra, Andrea, Alessandra Venanzi, Gianluca Schiavoni, et al.. (2021). Abstract LB044: Tracking clonal hematopoiesis in patients with classical Hodgkin lymphoma. Cancer Research. 81(13_Supplement). LB044–LB044. 1 indexed citations
5.
Pettirossi, Valentina, Alessia Santi, Alessandra Pucciarini, et al.. (2014). BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity. Blood. 125(8). 1207–1216. 58 indexed citations
6.
Pettirossi, Valentina, Alessia Santi, Alessandra Pucciarini, et al.. (2013). Targeting The BRAF-MEK-ERK Pathway In Hairy Cell Leukemia. Blood. 122(21). 3064–3064. 3 indexed citations
7.
Tiacci, Enrico, Gianluca Schiavoni, Maria Paola Martelli, et al.. (2013). Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia. Haematologica. 98(4). 635–639. 57 indexed citations
8.
Tiacci, Enrico, Gianluca Schiavoni, Francesco Forconi, et al.. (2011). Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood. 119(1). 192–195. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026